Home » WOCKHARDT GETS FDA NOD TO SELL DRUG IN U.S.
WOCKHARDT GETS FDA NOD TO SELL DRUG IN U.S.
May 15, 2006
Wockhardt has received US Food and Drug Administration (FDA) approval for marketing ceftriaxone sodium injection, a broad-spectrum new generation antibiotic, in the US market.
KEYWORDS Daily International Pharma Alert